Comment & Analysis
How the rich invest: Lang Walker experiments with biotechnology stocks
While billionaire property developer Lang Walker presses ahead with projects in Adelaide and Parramatta, and as the market waits to see what his next move is with the $2.5 billion Collins Square project in Melbourne, he is also dabbling in several listed biotech stocks. A perennial BRW Rich List member,…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Australian Financial Review